Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.6299
-3.09 %
$ 14.7 M
Market Cap
-0.28
P/E
CASH FLOW STATEMENT
-15.6 M
OPERATING CASH FLOW
-13.8 M
INVESTING CASH FLOW
12.7 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Cosmos Health Inc.
| Net Income | -18.5 M |
| Depreciation & Amortization | 614 K |
| Capital Expenditures | -9.17 M |
| Stock-Based Compensation | 578 K |
| Change in Working Capital | -7.9 M |
| Others | 5.84 M |
| Free Cash Flow | -23.9 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Jul-2011 | Jul-2010 | Jul-2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||||
| Net Income | (18.5) | (13.8) | (8.0) | 0.8 | (3.3) | (9.1) | (6.2) | (0.6) | (6.7) | 6.0 | 0.2 | 455 | (0.2) | (3.8) | 4.6 K |
| Depreciation & Amortization | 0.6 | 0.2 | 0.4 | 0.4 | 0.4 | 43.9 K | 25.9 K | 9.45 K | 5.42 K | 9.48 K | 0 | 0 | 0 | 0 | 0 |
| Deferred Income Tax | 78.6 K | 0.8 | (0.7) | (0.2) | 0 | 0 | 2.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 0.6 | 24.4 K | 5.9 | 0 | 0 | 0.2 | 0.3 | 16.6 K | 28.4 K | 0 | 0 | 0 | 63.2 K | 3.7 | 0 |
| Other Operating Activities | 9.5 | 6.7 | 1.5 | 0.2 | 1.7 | 6.6 | 0.9 | 16.1 K | 6.2 | (0.2) | 0.6 | 486 | 835 | 952 | 0 |
| Change in Working Capital | (7.9) | (8.7) | (6.3) | (11.9) | (3.6) | 0.7 | (6.2) | (1.6) | 6.55 K | 0.6 | 0.6 | 486 | 17.9 K | 2.52 K | 4.6 K |
| Cash From Operations | (15.6) | (14.9) | (7.1) | (11.5) | (4.8) | (1.6) | (8.8) | (2.1) | (0.5) | 6.5 | 0.8 | 31 | 87.3 K | 69.6 K | 0 |
| INVESTING CASH FLOW | |||||||||||||||
| Capital Expenditures | (9.2) | (0.4) | (0.9) | (0.1) | (0.7) | (0.5) | 55.3 K | 12.8 K | 44 K | 21.5 K | 0 | 0 | 0 | 0 | 0 |
| Other Items | (4.6) | 0.4 | 63.7 K | 0 | 1.3 | 0.3 | 40.9 K | (0.1) | 0 | (6.7) | 18.1 K | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | (13.8) | 21.5 K | (0.8) | (0.1) | 0.6 | (0.2) | 14.5 K | (0.1) | 44 K | (6.8) | 18.1 K | 0 | 0 | 0 | 0 |
| FINANCING CASH FLOW | |||||||||||||||
| Common Stock Repurchased | (0.1) | 0 | (0.4) | (0.2) | (0.8) | 80.1 K | 34.5 K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 21.4 K | (13.9) | 7.4 | 12.7 | 4.4 | 2.1 | 9.2 | 2.7 | 0.3 | 0.5 | 0 | 0 | 15.9 K | 15.9 K | 0 |
| Dividends Paid | 0 | (32.0) | (7.6) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 2.8 | 45.6 | 7.6 | 0 | 0 | 0 | 0 | 24.1 K | 0 | 0 | 2.37 K | 917 | 0 | 0 | 0 |
| Cash From Financing Activities | 12.7 | 35.0 | 7.3 | 12.5 | 3.6 | 2.0 | 9.3 | 2.7 | 0.3 | 0.5 | 2.37 K | 917 | 0.1 | 70.1 K | 0 |
| CHANGE IN CASH | |||||||||||||||
| Net Change In Cash | (16.9) | 20.5 | (0.3) | 0.6 | (0.8) | 81.5 K | 66.3 K | 0.5 | (0.2) | (0.4) | 0.9 | 0 | 14.8 K | 470 | 0 |
| FREE CASH FLOW | |||||||||||||||
| Free Cash Flow | (23.9) | (15.3) | (8.0) | (11.6) | (5.5) | (2.1) | (8.8) | (2.1) | (0.5) | 6.5 | 0.8 | 31 | 87.3 K | 69.6 K | 0 |